Literature DB >> 21725994

PUMA-mediated apoptosis drives chemical hepatocarcinogenesis in mice.

Wei Qiu1, Xinwei Wang, Brian Leibowitz, Wancai Yang, Lin Zhang, Jian Yu.   

Abstract

UNLABELLED: Hepatocyte death and proliferation contribute to hepatocellular carcinoma development after carcinogen exposure or chronic liver inflammation. However, the role and the molecular targets of hepatocyte death in relation to compensatory proliferation have not been fully characterized. In this study, we investigated the role of p53 up-regulated modulator of apoptosis (PUMA), a BH3-only protein important for both p53-dependent and -independent apoptosis, in a diethylnitrosamine (DEN)-induced liver carcinogenesis model. PUMA deficiency significantly decreased the multiplicity and size of liver tumors. DEN treatment induced p53-independent PUMA expression, PUMA-dependent hepatocyte death, and compensatory proliferation. Furthermore, inhibition or deletion of c-jun N-terminal kinase 1 (JNK1) abrogated PUMA induction, hepatocyte death, and compensatory proliferation.
CONCLUSION: These results provide direct evidence that JNK1/PUMA-dependent apoptosis promotes chemical hepatocarcinogenesis through compensatory proliferation, and suggest apoptotic inducers as potential therapeutic targets in liver injury and cancer.
Copyright © 2011 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21725994      PMCID: PMC3184207          DOI: 10.1002/hep.24516

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  57 in total

Review 1.  The Bcl-2 apoptotic switch in cancer development and therapy.

Authors:  J M Adams; S Cory
Journal:  Oncogene       Date:  2007-02-26       Impact factor: 9.867

Review 2.  TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer.

Authors:  S P Hussain; J Schwank; F Staib; X W Wang; C C Harris
Journal:  Oncogene       Date:  2007-04-02       Impact factor: 9.867

3.  TRAIL receptor-mediated JNK activation and Bim phosphorylation critically regulate Fas-mediated liver damage and lethality.

Authors:  Nadia Corazza; Sabine Jakob; Corinne Schaer; Steffen Frese; Adrian Keogh; Deborah Stroka; Daniela Kassahn; Ralph Torgler; Christoph Mueller; Pascal Schneider; Thomas Brunner
Journal:  J Clin Invest       Date:  2006-09       Impact factor: 14.808

4.  Can loss of apoptosis protect against cancer?

Authors:  Dominik Wodarz; Natalia Komarova
Journal:  Trends Genet       Date:  2007-03-26       Impact factor: 11.639

5.  Deletion of NEMO/IKKgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma.

Authors:  Tom Luedde; Naiara Beraza; Vasileios Kotsikoris; Geert van Loo; Arianna Nenci; Rita De Vos; Tania Roskams; Christian Trautwein; Manolis Pasparakis
Journal:  Cancer Cell       Date:  2007-02       Impact factor: 31.743

6.  p53 independent induction of PUMA mediates intestinal apoptosis in response to ischaemia-reperfusion.

Authors:  Bin Wu; Wei Qiu; Peng Wang; Hui Yu; Tao Cheng; Gerard P Zambetti; Lin Zhang; Jian Yu
Journal:  Gut       Date:  2006-11-24       Impact factor: 23.059

7.  c-Jun NH2-terminal kinase 1 plays a critical role in intestinal homeostasis and tumor suppression.

Authors:  Chang Tong; Zhinan Yin; Zibo Song; Ashley Dockendorff; Chuanshu Huang; John Mariadason; Richard A Flavell; Roger J Davis; Leonard H Augenlicht; Wancai Yang
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

8.  Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production.

Authors:  Willscott E Naugler; Toshiharu Sakurai; Sunhwa Kim; Shin Maeda; Kyounghyun Kim; Ahmed M Elsharkawy; Michael Karin
Journal:  Science       Date:  2007-07-06       Impact factor: 47.728

9.  Expressional and mutational analysis of pro-apoptotic Bcl-2 member PUMA in hepatocellular carcinomas.

Authors:  Chang H Ahn; Eun G Jeong; Sung S Kim; Jong W Lee; Sung H Lee; Sung H Kim; Min S Kim; Nam J Yoo; Sug Hyung Lee
Journal:  Dig Dis Sci       Date:  2007-10-13       Impact factor: 3.199

10.  Chemosensitization of head and neck cancer cells by PUMA.

Authors:  Quanhong Sun; Tsukasa Sakaida; Wen Yue; Susanne M Gollin; Jian Yu
Journal:  Mol Cancer Ther       Date:  2007-12       Impact factor: 6.261

View more
  41 in total

Review 1.  How do persistent infections with hepatitis C virus cause liver cancer?

Authors:  Jonathan K Mitchell; Stanley M Lemon; David R McGivern
Journal:  Curr Opin Virol       Date:  2015-09-29       Impact factor: 7.090

2.  Is hepatitis C virus carcinogenic?

Authors:  Stanley M Lemon; David R McGivern
Journal:  Gastroenterology       Date:  2012-05       Impact factor: 22.682

3.  Bid-ding for mercy: twisted killer in action.

Authors:  A Egle; D Asslaber; A Villunger; J Pinon-Hofbauer
Journal:  Cell Death Differ       Date:  2013-07       Impact factor: 15.828

Review 4.  JNK signalling in cancer: in need of new, smarter therapeutic targets.

Authors:  Concetta Bubici; Salvatore Papa
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

5.  Targeting p53-dependent stem cell loss for intestinal chemoprotection.

Authors:  Brian J Leibowitz; Liheng Yang; Liang Wei; Monica E Buchanan; Madani Rachid; Robert A Parise; Jan H Beumer; Julie L Eiseman; Robert E Schoen; Lin Zhang; Jian Yu
Journal:  Sci Transl Med       Date:  2018-02-07       Impact factor: 17.956

6.  p53 Up-regulated Modulator of Apoptosis Induction Mediates Acetaminophen-Induced Necrosis and Liver Injury in Mice.

Authors:  Dongshi Chen; Hong-Min Ni; Lei Wang; Xiaowen Ma; Jian Yu; Wen-Xing Ding; Lin Zhang
Journal:  Hepatology       Date:  2019-03-11       Impact factor: 17.425

Review 7.  A fate worse than death: apoptosis as an oncogenic process.

Authors:  Gabriel Ichim; Stephen W G Tait
Journal:  Nat Rev Cancer       Date:  2016-07-01       Impact factor: 60.716

8.  Inhibition of SIRT2 suppresses hepatic fibrosis.

Authors:  Maribel Arteaga; Na Shang; Xianzhong Ding; Sherri Yong; Scott J Cotler; Mitchell F Denning; Takashi Shimamura; Peter Breslin; Bernhard Lüscher; Wei Qiu
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-04-28       Impact factor: 4.052

9.  Deficiency of G-protein-coupled bile acid receptor Gpbar1 (TGR5) enhances chemically induced liver carcinogenesis.

Authors:  Wei-Dong Chen; Donna Yu; Barry M Forman; Wendong Huang; Yan-Dong Wang
Journal:  Hepatology       Date:  2013-02       Impact factor: 17.425

10.  The p53-PUMA axis suppresses iPSC generation.

Authors:  Yanxin Li; Haizhong Feng; Haihui Gu; Dale W Lewis; Youzhong Yuan; Lei Zhang; Hui Yu; Peng Zhang; Haizi Cheng; Weimin Miao; Weiping Yuan; Shi-Yuan Cheng; Susanne M Gollin; Tao Cheng
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.